Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1901
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIchikawa, H-
dc.contributor.authorMangalam S Nair-
dc.contributor.authorTakada, Y-
dc.contributor.authorAlan Sheeja, D B-
dc.contributor.authorSuresh Kumar, M A-
dc.contributor.authorOommen, O V-
dc.contributor.authorAggarwal, B B-
dc.date.accessioned2015-08-06T05:37:53Z-
dc.date.available2015-08-06T05:37:53Z-
dc.date.issued2006-
dc.identifier.citationClinical Cancer Research 12(19):5910-5918;1 Oct 2006en_US
dc.identifier.issn1078-0432-
dc.identifier.urihttp://ir.niist.res.in:8080/jspui/handle/123456789/1901-
dc.description.abstractPurpose: Deoxyelephantopin (ESD) and isodeoxyelephantopin (ESI) are two sesquiterpene lactones derived from the medicinal plant Elephantopus scaber Linn. (Asteraceae). Although they are used for the treatment of a wide variety of proinflammatory diseases, very little is known about their mechanism of action. Because most genes that control inflammation are regulated by activation of the transcription factor nuclear factor-kappa B (NF-kappa B), we postulated that ESD and ESI mediate their activities through modulation of the NF-kappa B activation pathway. Experimental Design: We investigated the effect of ESI and ESD on NF-kappa B activation by electrophoretic mobility shift assay and NF-kappa B-regulated gene expression by Western blot analysis. Results: We found that ESI suppressed NF-kappa B activation induced by a wide variety of inflammatory agents, including tumor necrosis factor (TNF), interleukin-1 beta phorbol 12-myristate 13-acetate, and lipopolysaccharide. The suppression was not cell type specific, and both inducible and constitutive NF-kappa B activation was blocked. ESI did not interfere with the binding of NF-kappa B to DNA but rather inhibited I kappa B alpha kinase, I kappa B alpha phosphorylation, I kappa B alpha degradation, p65 phosphorylation, and subsequent p65 nuclear translocation. ESI also suppressed the expression of TNF-induced NF-kappa B-regulated, proliferative, antiapoptotic, and metastatic gene products. These effects correlated with enhancement of apoptosis induced by TNF and suppression of TNF-induced invasion and receptor activator of NF-kappa B ligand-induced osteoclastogenesis. Conclusion: Our results indicate that ESI inhibits NF-kappa B activation and NF-kappa B-regulated gene expression, which may explain the ability of ESI to enhance apoptosis and inhibit invasion and osteoclastogenesis.en_US
dc.language.isoenen_US
dc.publisherAmerican Association for Cancer Researchen_US
dc.subjectTumor-necrosis-factoren_US
dc.subjectAlpha-induced apoptosisen_US
dc.subjectTranscription factoren_US
dc.subjectP65 phosphorylationen_US
dc.titleIsodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappa B (NF-kappa B) activation and NF-kappa B-regulated gene expressionen_US
dc.typeArticleen_US
Appears in Collections:2006

Files in This Item:
File Description SizeFormat 
2006_0045.PDF
  Restricted Access
594.3 kBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.